Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Magenta Therapeutics Inc
(NQ:
MGTA
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 11, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Magenta Therapeutics Inc
< Previous
1
2
3
4
Next >
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
May 31, 2021
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 18, 2021
Gainers Onconova Therapeutics (NASDAQ:ONTX) shares moved upwards by 41.84% to $0.88 during Tuesday's regular session. As of 12:30 EST, this security is trading at a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2021
May 18, 2021
Upgrades Janney Montgomery Scott upgraded the previous rating for Centerspace (NYSE:CSR) from Neutral to Buy. In the first quarter, Centerspace showed an EPS of $0.95,...
Via
Benzinga
Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in May
May 14, 2021
From
Magenta Therapeutics
Via
Business Wire
Magenta Therapeutics Announces Positive Preliminary Results from Phase 2 Clinical Trial of MGTA-145 in Multiple Myeloma and Provides an Update on its Anticipated Clinical Study with MGTA-117
May 12, 2021
From
Magenta Therapeutics
Via
Business Wire
Magenta Therapeutics Announces $86.4 Million Common Stock Investment from Multiple Investors
May 12, 2021
From
Magenta Therapeutics, Inc.
Via
Business Wire
Magenta Therapeutics Reports First Quarter Financial Results and Recent Program Highlights
May 06, 2021
From
Magenta Therapeutics
Via
Business Wire
Magenta Therapeutics Appoints David Nichols as Chief Technical Officer
April 19, 2021
From
Magenta Therapeutics
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.